Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Riociguat in Renal Impairment
NCT04364464Phase 1Completed
- Sponsor
- Bayer
- Start
- Feb 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of riociguat in pulmonary hypertension (PH) (4 arms), sponsored by Bayer. Primary endpoints: Area Under the Curve at 72 hours, Maximum Plasma Concentration at 72 hours and 4 more. Started Feb 2010; status: completed.
02
Drugs
riociguat
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT04364464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04364464.